Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial

Amantadine and the Risk of Dyskinesia in Patients with Early Parkinson’s Disease: An Open-Label, Pragmatic Trial

Objective We examined whether amantadine can prevent the development of dyskinesia. Methods Patients with drug-naïve Parkinson’s disease (PD), younger than 70 years of age and in the early stage of PD (Hoehn and Yahr scale < 3), were recruited from April 2011 to December 2014. The exclusion crite...

Full description

Bibliographic Details
Main Authors: Aryun Kim, Young Eun Kim, Ji Young Yun, Han-Joon Kim, Hui-Jun Yang, Woong-Woo Lee, Chae Won Shin, Hyeyoung Park, Yu Jin Jung, Ahro Kim, Yoon Kim, Mihee Jang, Beomseok Jeon
Format: Article
Language:English
Published: Korean Movement Disorders Society 2018-05-01
Series:Journal of Movement Disorders
Subjects:
Amantadine
dyskinesias
Parkinson’s disease
levodopa
Online Access:http://www.e-jmd.org/upload/jmd-18005.pdf

Internet

http://www.e-jmd.org/upload/jmd-18005.pdf

Similar Items